NYSE:GWRE - New York Stock Exchange, Inc. - US40171V1008 - Common Stock - Currency: USD
DocuSign crushed its last quarter and is expected to report another strong quarter. This is a "great entry point," Bryn Talkington says.
12 large-cap stocks saw significant gains last week, including Summit Therapeutics, Rocket Lab, Moderna, and Netflix. Analysts raised price forecasts.
Shares of insurance industry-focused software maker Guidewire (NYSE:GWRE) jumped 9.7% in the afternoon session after Goldman Sachs analyst Adam Hotchkiss initiated coverage of the stock with a Buy rating and a $210 price target. Hotchkiss thinks Guidewire's leadership in the key end markets and the momentum from customers migrating to the cloud should continue to support growth.
Shares of insurance industry-focused software maker Guidewire (NYSE:GWRE) jumped 9.7% in the afternoon session after Goldman Sachs analyst Adam Hotchkiss initiated coverage of the stock with a Buy rating and a $210 price target. Hotchkiss thinks Guidewire's leadership in the key end markets and the momentum from customers migrating to the cloud should continue to support growth.
/PRNewswire/ -- Guidewire Software Inc. (NYSE: GWRE) will replace Arrowhead Pharmaceuticals Inc. (NASD: ARWR) in the S&P MidCap 400, and Arrowhead...
Let’s dig into the relative performance of Guidewire (NYSE:GWRE) and its peers as we unravel the now-completed Q3 vertical software earnings season.
Guidewire Software had another solid quarter, including improved guidance, with analysts lifting their price targets and leading the market to new highs.